Results 231 to 240 of about 213,637 (257)

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

Highlights of ASCO 2026. [PDF]

Oncologist
DaSilva BA, Neugut AI, Fojo T, Bates SE.
europepmc   +1 more source

Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells. [PDF]

Cancer Rep (Hoboken)
Koyanagi T, Saga Y, Takahashi Y, Tamura K, Suizu E, Yamamoto K, Taneichi A, Takei Y, Mizukami H, Fujiwara H.   +9 more
europepmc   +1 more source

Epigenetic Landscape and Regulation of Secondary Metabolite Accumulation Implicated in Anticancer and Nutraceuticals. [PDF]

Epigenomes
Kosaraju D, Jarapala VN, Yeddala A, Polavarapu C, Singareddy V, Palakolanu SR, Sreenivasulu N, Kishor PBK.   +7 more
europepmc   +1 more source

Proteomic Adaptations in the Spinal Cord of a Breast Cancer Model of Paclitaxel-Induced Peripheral Neuropathy. [PDF]

J Proteome Res
Schwarting SP, Espina V, Russo PS, Herz SM, Khan A, Rakholia Y, Makar S, Bos PD, Damaj MI, Kabbani N.   +9 more
europepmc   +1 more source

DHX9 Inhibition Enhances Paclitaxel Sensitivity by Inducing Mitotic Failure in Ovarian and Endometrial Cancers. [PDF]

Mol Cancer Ther
Huang TT, Nair JR, Bowen C, Castro J, Nousome D, Nayak S, Silver SJ, Lee JM.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

Annals of Oncology, 2021
Hong Tu, Y L Wu, P Shen
exaly  

Synthetic biology identifies the minimal gene set required for paclitaxel biosynthesis in a plant chassis

Molecular Plant, 2023
John Molloy, Alisdair R Fernie, Mathias Christmann   +2 more
exaly